BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31574794)

  • 1. Kuntai capsules improve glucolipid metabolism in patients with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.
    Liang R; Liu Z; Li P; Fan P; Xu L; Sun X; Peng J; Peng X; Zhang M
    Medicine (Baltimore); 2019 Sep; 98(39):e16788. PubMed ID: 31574794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of Qingre Yangyin Recipe on Endocrine and Metabolism of Polycystic Ovary Syndrome Patients].
    Zhang T
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Oct; 35(10):1175-80. PubMed ID: 26677666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women?
    Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J
    Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of abdominal acupuncture therapy on the endocrine and metabolism in obesity-type polycystic ovarian syndrome patients].
    Lai MH; Ma HX; Yao H; Liu H; Song XH; Huang WY; Wu XK
    Zhen Ci Yan Jiu; 2010 Aug; 35(4):298-302. PubMed ID: 21090334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone for treating polycystic ovary syndrome in non-obese women of reproductive age with different clinical presentations.
    Koo YA; Shin SY; Yoon BK; Choi D
    Gynecol Endocrinol; 2007; 23(8):461-7. PubMed ID: 17852414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of abdominal acupuncture for patients with obesity-type polycystic ovary syndrome: a randomized controlled trial.
    Zheng YH; Wang XH; Lai MH; Yao H; Liu H; Ma HX
    J Altern Complement Med; 2013 Sep; 19(9):740-5. PubMed ID: 23676106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Predictive Role of Serum Cystatin C Levels in Polycystic Ovary Syndrome in Adolescents.
    Çınar M; Aksoy RT; Güzel Aİ; Tokmak A; Çandar T; Taşçı Y
    J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):353-6. PubMed ID: 26740281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of luteinizing hormone vs follicular stimulating hormone ratio on anti-Müllerian hormone secretion and folliculogenesis in patients with polycystic ovarian syndrome].
    Li Y; Wei LN; Xiong YL; Liang XY
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):567-70. PubMed ID: 21029609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine and metabolic characteristics of polycystic ovary syndrome in Chinese women with different phenotypes.
    Xu X; Shi Y; Cui Y; Ma J; Che L; Chen ZJ
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):425-30. PubMed ID: 21815904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Oligopin Supplementation on Hormonal and Metabolic Profiles in the Polycystic Ovary Syndrome: A Randomized Controlled Trial.
    Qorbani M; Sanginabadi M; Mohajeri-Tehrani MR; Karimi S; Gerami H; Mahdavi-Gorabi A; Shirzad N; Samadi M; Baygi F; Hosseini S; Mansour A
    Front Endocrinol (Lausanne); 2020; 11():590392. PubMed ID: 33408691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin Is Associated With Insulin Resistance and Beta-Cell Dysfunction in Infertile Women With Polycystic Ovary Syndrome.
    Yang H; Lin J; Li H; Liu Z; Chen X; Chen Q
    Front Endocrinol (Lausanne); 2021; 12():571229. PubMed ID: 33716958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the significance of sex hormone-binding globulin examination in the treament of women with polycystic ovarian syndrome (PCOS).
    Lin XF; Wu RR; Du J; Liao YC; Du Y; Ye Y; Wang Y; Zhang XB; Wu C; Chen A
    Clin Exp Obstet Gynecol; 2015; 42(3):315-20. PubMed ID: 26152001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial.
    Fux Otta C; Wior M; Iraci GS; Kaplan R; Torres D; Gaido MI; Wyse EP
    Gynecol Endocrinol; 2010 Mar; 26(3):173-8. PubMed ID: 20148739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of resolving method of Chinese medicine on the lipid metabolism in polycystic ovary syndrome accompanied with non-alcoholic fatty liver disease].
    Chen Y; Wang XJ; Jin HL; Jin L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):751-6. PubMed ID: 23980352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
    Wan DH; Fan P; Bai H; Song Q; Liu HW
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.